Literature DB >> 34925950

The distribution of disease in the Republic of Suriname - A pharmacoepidemiological analysis using the claims database of the State Health Foundation of the year 2017.

Vinoj H Sewberath Misser1, Arti Shankar2, Ashna Hindori-Mohangoo2,3, Jeffrey Wickliffe2,4, Maureen Lichtveld2,5, Dennis R A Mans1.   

Abstract

The patterns of prescription drug use in Suriname in the year 2017 have been determined with the purpose of obtaining indications about the distribution of disease in the country. The claims database of the State Health Foundation (Staatsziekenfonds, SZF) of Suriname was used for calculations of prescription rates of the fifty most prescribed drugs overall and after stratification according to gender, age, and residence of the insured persons. Information in the database had been de-identified, and the prescribed medicines had been coded according to the Anatomic Therapeutic Chemical Classification System. Statistically significant differences among the prescription rates were assessed with the two samples test of proportions using normal theory method and χ2 Goodness of Fit tests (p < 0.05). Additionally, the Bonferroni adjustment was used to adjust for type 1 error inflation resulting from multiple comparisons. Overall, drugs for the cardiovascular, respiratory, and musculo-skeletal systems had the highest prescription rates (p < 0.001). Furthermore, rates were generally higher in females than in males, in the older age groups than in younger individuals, and in the coastal regions compared to the country's interior (p < 0.001). These findings are largely in line with data found in the literature and support the use of this pharmacoepidemiological approach to assess the distribution of disease in Suriname.

Entities:  

Keywords:  Suriname; claims database; distribution of disease; pharmacoepidemiology; prescription drugs

Year:  2021        PMID: 34925950      PMCID: PMC8682966     

Source DB:  PubMed          Journal:  J Public Health Epidemiol        ISSN: 2141-2316


  32 in total

1.  Monitoring drug safety with registries: useful components of postmarketing pharmacovigilance systems.

Authors:  Cameron D Willis; John J McNeil; Peter A Cameron; Louise E Phillips
Journal:  J Clin Epidemiol       Date:  2011-10-08       Impact factor: 6.437

Review 2.  Symptoms, risk factors, diagnosis and treatment of urinary tract infections.

Authors:  Rajanbir Kaur; Rajinder Kaur
Journal:  Postgrad Med J       Date:  2020-11-24       Impact factor: 2.401

Review 3.  Gender difference in the pathophysiology and treatment of glaucoma.

Authors:  Shandiz Tehrani
Journal:  Curr Eye Res       Date:  2014-10-06       Impact factor: 2.424

4.  Can we use the pharmacy data to estimate the prevalence of chronic conditions? a comparison of multiple data sources.

Authors:  Francesco Chini; Patrizio Pezzotti; Letizia Orzella; Piero Borgia; Gabriella Guasticchi
Journal:  BMC Public Health       Date:  2011-09-05       Impact factor: 3.295

5.  Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications.

Authors:  Carola A Huber; Thomas D Szucs; Roland Rapold; Oliver Reich
Journal:  BMC Public Health       Date:  2013-10-30       Impact factor: 3.295

6.  Quantifying Geographic Variation in Health Care Outcomes in the United States before and after Risk-Adjustment.

Authors:  Barry L Rosenberg; Joshua A Kellar; Anna Labno; David H M Matheson; Michael Ringel; Paige VonAchen; Richard I Lesser; Yue Li; Justin B Dimick; Atul A Gawande; Stefan H Larsson; Hamilton Moses
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

7.  Prevalence, risk factors and microorganisms of urinary tract infections in patients with type 2 diabetes mellitus: a retrospective study in China.

Authors:  Ke He; Yun Hu; Jun-Cheng Shi; Yun-Qing Zhu; Xiao-Ming Mao
Journal:  Ther Clin Risk Manag       Date:  2018-02-26       Impact factor: 2.423

8.  Malaria epidemiology in Suriname from 2000 to 2016: trends, opportunities and challenges for elimination.

Authors:  Hélène Hiwat; Beatriz Martínez-López; Hedley Cairo; Loretta Hardjopawiro; Agatha Boerleider; Elisabeth Carmen Duarte; Zaida E Yadon
Journal:  Malar J       Date:  2018-11-12       Impact factor: 2.979

9.  Epidemiology of respiratory viruses in patients with severe acute respiratory infections and influenza-like illness in Suriname.

Authors:  Meritha Grunberg; Rachel Sno; Malti R Adhin
Journal:  Influenza Other Respir Viruses       Date:  2020-09-02       Impact factor: 4.380

10.  Decreased endemic malaria in Suriname: moving towards elimination.

Authors:  Edward D van Eer; Gustavo Bretas; Hélène Hiwat
Journal:  Malar J       Date:  2018-01-30       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.